Paclitaxel-loaded PCL-TPGS nanoparticles: In vitro and in vivo performance compared with Abraxane®

Colloids and Surfaces B: Biointerfaces

Volumn 113, Issue , 2014, Pages 43-50

  Bernabeu, Ezequiel ^a   Helguera, Gustavo ^a   Legaspi, Maria J ^a   Gonzalez, Lorena ^a   Hocht, Christian ^a   Taira, Carlos ^a   Chiappetta, Diego A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

In vitro anti tumoral activity; In vivo pharmacokinetic studies; Paclitaxel; PCL TPGS; Polymeric nanoparticles

Indexed keywords

CELL CULTURE; CELLS; CHEMOTHERAPY; DISEASES; EMULSIFICATION; EVAPORATION;

ANTI-TUMORAL ACTIVITY; IN-VIVO; PACLITAXEL; PCL-TPGS; POLYMERIC NANOPARTICLES;

NANOPARTICLES;

NANOPARTICLE; PACLITAXEL; POLYCAPROLACTONE ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; EMULSION SOLVENT EVAPORATION; EVAPORATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MALE; NANOPRECIPITATION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; RAT;

IN VITRO ANTI-TUMORAL ACTIVITY; IN VIVO PHARMACOKINETIC STUDIES; PACLITAXEL; PCL-TPGS; POLYMERIC NANOPARTICLES;

ALBUMINS; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; NANOPARTICLES; PACLITAXEL; POLYESTERS; POLYETHYLENE GLYCOLS; POLYMERS; RATS; RATS, WISTAR; VITAMIN E;

EID: 84884376600     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.07.036     Document Type: Article

References (50)

1. WHO - World Cancer Day - "Together it is possible". (accessed January 2013). http://www.who.int/cancer/en/.
2. GLOBOCAN 2008 Estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008. (accessed January 2013). http://globocan.iarc.fr/.
3. WHO - Breast cancer: prevention and control. (accessed January 2013). http://www.who.int/cancer/detection/breastcancer/en/index.html.
4. Gennari A., Conte P., Rosso R., Orlandini C., Bruzzi P. Cancer 2005, 104:1742.
5. Ma G., Yang J., Zhang L., Song C. Anticancer Drugs 2010, 21:261.
6. Cirstoiu-Hapca A., Buchegger F., Lange N., Bossy L., Gurny R., Delie F. J. Control. Release 2010, 144:324.
7. Singla A.K., Garg A., Aggarwal D. Int. J. Pharm. 2002, 235:179.
8. Yoncheva K., Calleja P., Agüeros M., Petrov P., Miladinova I., Tsvetanov C., Irache J.M. Int. J. Pharm. 2012, 436:258.
9. Lee S.-Ch., Huh K.-M., Lee J., Cho Y.-W., Galinsky R.E., Park K. Biomacromolecules 2007, 8:202.
10. Gelderblom H., Verweij J., Nooter K., Sparreboom A. Eur. J. Cancer 2001, 37:1590.
11. Singh S., Dash A.K. Crit. Rev. Ther. Drug Carrier Syst. 2009, 26:333.
12. Meerum Terwogt J.M., Nuijent B., Ten Bokkel Huinink W.W., Beijnen J.H. Cancer Treat. Rev. 1997, 23:87.
13. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. J. Control. Release 2000, 65:271.
14. Crosasso P., Ceruti M., Brusa P., Arpicco S., Dosio F., Cattel L. J. Control. Release 2000, 63:19.
15. Yang T., Cui F.-D., Choi M.-K., Cho J.-W., Chung S.-J., Shim C.-K., Kim D.-D. Int. J. Pharm. 2007, 338:317.
16. Cavalli R., Caputo O., Gasco M.R. Eur. J. Pharm. Sci. 2000, 10:305.
17. Chen D.-B., Yang T.-Z., Lu W.-L., Zhang Q. Chem. Pharm. Bull. 2001, 49:1444.
18. Danhier F., Lecouturier N., Vroman B., JérÔme C., Marchand-Brynaert J., Feron O., Préat V. J. Control. Release 2009, 133:11.
19. Wei Z., Hao J., Yuan S., Li Y., Juan W., Sha X., Fang X. Int. J. Pharm. 2009, 376:176.
20. Zhang W., Shi Y., Chen Y., Hao J., Sha X., Fang X. Biomaterials 2011, 32:5934.
21. Park I.-K., Kim Y.-J., Tran T.-H., Huh K.-M., Lee Y.-K. Polymer 2010, 51:3387.
22. Yang D., Liu X., Jiang X., Liu Y., Ying W., Wang H., Bai H., Taylor W.D., Wang Y., Clamme J.P., Co E., Chivukula P., Tsang K.Y., Jin Y., Yu L. J. Control. Release 2012, 161:124.
23. Gradishar W.J. Expert Opin. Pharmacother. 2006, 7:1041.
24. Sparreboom A., Scripture C.D., Trieu V., Williams P.J., De T., Yang A., Beals B., Figg W.D., Hawkins M., Desai N. Clin. Cancer Res. 2005, 11:4136.
25. Bernabeu E., Chiappetta D.A. J. Biomater. Tissue Eng. 2013, 3:122.
26. Youk H.J., Lee E., Choi M.K., Lee Y.J., Chung J.H., Kim S.H., Lee C.H., Lim S.J. J. Control. Release 2005, 107:43.
27. Puga A.M., Rey-Rico A., Magariños B., Alvarez-Lorenzo C., Concheiro A. Acta Biomater. 2012, 8:1507.
28. Kappe C.O. Angew. Chem. Int. Ed. 2004, 43:6250.
29. Wang Y.-J., Wang C., Gong C.-Y., Wang Y.-J., Guo G., Luo F., Qian Z.-Y. Int. J. Pharm. 2012, 434:1.
30. Costa P., Sousa Lobo J.M. Eur. J. Pharm. Sci. 2001, 13:123.
31. Schwach G., Vert Int M. J. Biol. Macromol. 1999, 25:283.
32. Feng S.-S., Mei L., Anitha P., Gan C.W., Zhou W. Biomaterials 2009, 30:3297.
33. Zhang Z., Feng S.-S. Biomaterials 2006, 27:262.
34. Ma Y., Huang L., Song C., Zeng X., Liu G., Mei L. Polymer 2010, 51:5952.
35. Moretton M.A., Glisoni R.J., Chiappetta D.A., Sosnik A. Colloids Surf. B: Biointerfaces 2010, 79:467.
36. Prasad Rao J., Geckeler K.E. Prog. Polym. Sci. 2011, 36:887.
37. Mu L., Feng S.S. J. Control. Release 2003, 86:33.
38. Danhier F., Feron O., Préat V. J. Control. Release 2010, 148:135.
39. Lince F., Marchisio D.L., Barresi A.A. J. Colloid Interface Sci. 2008, 322:505.
40. Cheow W.S., Chang M.W., Hadinoto K. Pharm. Res. 2010, 27:1597.
41. Siepmann J., Siepmann F. Int. J. Pharm. 2008, 364:328.
42. Debrassi A., Bürger C., Rodrigues C.A., Nedelko N., Ślawska-Waniewska A., Dłużewski P., Sobczak K., Greneche J.M. Acta Biomater. 2011, 7:3078.
43. Constantinou C., Papas A., Constantinou A.I. Int. J. Cancer 2008, 123:739.
44. Neuzil J., Tomasetti M., Zhao Y., Dong L.-F., Birringer M., Wang X.-F., Low P., Wu K., Salvatore B.A., Ralph S.J. Mol. Pharmacol. 2007, 71:1185.
45. Neophytou C.M., Constantinou C., Constantinou A.I. Cancer Res. 2012, 72(Suppl. 1).
46. Tate C.R., Rhodes L.V., Chris Segar H., Driver J.L., Nell Pounder F., Burow M.E., Collins-Burow B.M. Breast Cancer Res. 2012, 14:R79.
47. Zhao L., Feng S.-S. J. Pharm. Sci. 2010, 99:3552.
48. Zhang Z., Feng S.-S. Biomaterials 2006, 27:4025.
49. Dong Y., Feng S.-S. Biomaterials 2007, 28:4154.
50. Hamaguchi T., Matsumura Y., Suzuki M., Shimizu K., Goda R., Nakamura I., Nakatomi I., Yokoyama M., Kataoka K., Kakizoe T. Br. J. Cancer 2005, 92:1240.